Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE

Annovis Bio, Inc. (NYSE: ANVS) announced on October 30, 2026, that it received a notice from the New York Stock Exchange (NYSE) on October 29, 2026. The notice stated that the company is no longer in compliance with NYSE continued listing standards because its average market capitalization over a 30-trading-day period was less than $50 million, and its stockholders' equity was less than $50 million. The company will submit a plan within 45 days to regain compliance within nine months.